Tesamorelin 10mg
$65.00
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog, used primarily to reduce visceral fat in patients with HIV-related lipodystrophy.
Key Features and Mechanisms of Action:
- Growth Hormone Release: Stimulates the release of growth hormone from the pituitary gland, enhancing fat metabolism and muscle growth.
- Fat Reduction: Primarily used to reduce abdominal fat in individuals with lipodystrophy.
Clinical and Therapeutic Potential:
- HIV-Related Lipodystrophy: Approved for reducing visceral fat accumulation in patients with this condition.
- Metabolic Disorders: Being studied for its potential in reducing fat in other metabolic disorders.
- Clinical Trials: Tesamorelin has been approved for use in specific cases of lipodystrophy, with ongoing research into other fat-reduction applications.
- Commercial Availability: Available for therapeutic use in lipodystrophy.
Description
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog, used primarily to reduce visceral fat in patients with HIV-related lipodystrophy.
Key Features and Mechanisms of Action:
- Growth Hormone Release: Stimulates the release of growth hormone from the pituitary gland, enhancing fat metabolism and muscle growth.
- Fat Reduction: Primarily used to reduce abdominal fat in individuals with lipodystrophy.
Clinical and Therapeutic Potential:
- HIV-Related Lipodystrophy: Approved for reducing visceral fat accumulation in patients with this condition.
- Metabolic Disorders: Being studied for its potential in reducing fat in other metabolic disorders.
Research and Development:
- Clinical Trials: Tesamorelin has been approved for use in specific cases of lipodystrophy, with ongoing research into other fat-reduction applications.
- Commercial Availability: Available for therapeutic use in lipodystrophy.
Reviews
There are no reviews yet.